Arab Drug Co. is aiming for net profits of EGP 3.5 million in the fiscal year 2015/16, the company said in a bourse statement Wednesday.

The company also said its shareholders approved the estimated budget for FY15/16.

The pharmaceutical company posted EGP 1.75 million in net profits for the six-months ended 31 December 2014, a rise of 40% from the same period of the previous year.

The firm is capitalised at EGP 60 million, distributed across 6 million shares at EGP 10 par value each.